RISK FACTORS FOR BILE LEAKAGE AFTER HEPATECTOMY FOR HEPATOCELLULAR CARCINOMA IN 359 RECENT CASES
Hiroshi Sadamori(Okayama University), Toshiyosi Fujiwara, Hiroaki Matsuda(Okayama University), Daisuke Satoh(Okayama University), Masashi Utsumi(Okayama University), Yuzo Umeda(Okayama University), Susumu Shinoura(Okayama University), Kazuhiro Yoshida(Nagasaki University), Takahito Yagi(Okayama University), Daisuke Nobuoka(Fukuyama City Hospital), Ryuichi Yoshida(Okayama University)
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
January 1, 2011
Cited by 0
Related Papers
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall Survival
|Clinical Cancer Research|2012|304
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
|OncoImmunology|2016|178
MiR‐133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle‐splicer polypyrimidine tract‐binding protein 1
|Cancer Science|2016|123
Risk factors for major morbidity after liver resection for hepatocellular carcinoma
|British journal of surgery|2012|104